Persistently increased expression of the transforming growth factor-β1 gene in human vascular restenosis: Analysis of 62 patients with one or more episode of restenosis

Sato, 1990, Characterization of the activation of latent TGF-β by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system, J Cell Biol, 111, 757, 10.1083/jcb.111.2.757 Okuda, 1990, Elevated expression of transforming growth factor-β and porteoglycan production in experimental glomerulonephritis, J Clin Invest, 86, 453, 10.1172/JCI114731 Chen, 1987, Transforming growth factor-β specifically stimulates synthesis of proteoglycan in human arterial smooth muscle cells, 84, 5287 Battegay, 1990, TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop, Cell, 63, 515, 10.1016/0092-8674(90)90448-N Winokur, 1991, Expression of transforming growth factors-β 1, 2 and 3 following vascular injury, J Cell Biochem, 15C, G414 Madri, 1989, Endothelial cell behavior after denudation injury is modulated by transforming growth factor-β1 and fibronectin, Lab Invest, 60, 755 Majesky, 1991, Production of transforming growth factor-β1 during repair of arterial injury, J Clin Invest, 88, 904, 10.1172/JCI115393 Schoenherr, 1991, Effects of platelet-derived growth factor and transforming growth factor-β on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells, J Biol Chem, 266, 17640, 10.1016/S0021-9258(19)47419-X Bassols, 1988, Transforming growth factor-β regulates the expression and structures of extracellular matrix chondroitin/dermatan sulfate proteoglycans, J Biol Chem, 263, 3039, 10.1016/S0021-9258(18)69173-2 Nikol, 1992, Expression of transforming growth factor-β1 is increased in human vascular restenosis lesions, J Clin Invest, 90, 1582, 10.1172/JCI116027 Rakugi, 1992, Expression of transforming growth factor beta 1 in human atherectomy specimens from primary- and restenotic coronary artery lesions, J Am Coll Cardiol, 19, 329A Simpson, 1988, Transluminal atherectomy for occlusive peripheral vascular disease, Am J Cardiol, 61, 96G, 10.1016/S0002-9149(88)80040-7 Safian, 1990, Coronary atherectomy: clinical, angiographic, and histological findings and observations regarding potential mechanisms, Circulation, 82, 69, 10.1161/01.CIR.82.1.69 Ardinger, 1988, RFLP for the human growth factor-β gene (TGFβ) on chromosome 19, Nucleic Acids Res, 16, 8202, 10.1093/nar/16.16.8202 Saez, 1990, Human nonmuscle myosin heavy chain mRNA: generation of diversity through alternative polyadenylation, 87, 1164 Simons, 1991, Human nonmuscle myosin heavy chains are encoded by two genes located on different chromosomes, Circ Res, 69, 530, 10.1161/01.RES.69.2.530 Nikol, 1992, Nonmuscle myosin: two isoforms with different functions in vascular restenosis, J Am Coll Cardiol, 19, 166A Johnson, 1990, Primary peripheral arterial stenoses and restenoses excised by transluminal atherectomy: a histopathologic study, J Am Coll Cardiol, 15, 419, 10.1016/S0735-1097(10)80071-3 Garratt, 1991, Differential histopathology of primary atherosclerotic and restenotic lesions in coronary arteries and saphenous vein bypass grafts: analysis of tissue obtained from 73 patients by directional atherectomy, J Am Coll Cardiol, 17, 442, 10.1016/S0735-1097(10)80113-5 Leclerc, 1992, Evidence implicating nonmuscle myosin in restenosis: use of in situ hybridization to analyze human vascular lesions obtained by directional atherectomy, Circulation, 85, 543, 10.1161/01.CIR.85.2.543 Majack, 1987, Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures, J Cell Biol, 105, 465, 10.1083/jcb.105.1.465 Owens, 1988, Transforming growth factor-β-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells, J Cell Biol, 107, 771, 10.1083/jcb.107.2.771 Border, 1990, Suppression of experimental glomerulonephritis by antiserum against transforming growth factor-β1, Nature, 346, 371, 10.1038/346371a0 Border, 1990, Transforming growth factor-β regulates production of proteoglycans by mesangial cells, Kidney Int, 37, 689, 10.1038/ki.1990.35 Shah, 1992, Control of scarring in adult wounds by neutralising antibody to transforming growth factor β, Lancet, 339, 213, 10.1016/0140-6736(92)90009-R Ross, 1986, The pathogenesis of atherosclerosis—an update, N Engl J Med, 314, 488, 10.1056/NEJM198602203140806 Miyazono, 1988, Latent high molecular weight complex of transforming growth factor β1: purification from human platelets and structural characterization, J Biol Chem, 263, 6407, 10.1016/S0021-9258(18)68800-3 Wakefield, 1989, Recombinant TGF-β1 is synthesized as a two-component latent complex that shares some structural features with the native platelet latent TGF-β1 complex, Growth Factors, 1, 203, 10.3109/08977198908997997 Derynck, 1986, The murine transforming growth factor-β precursor, J Biol Chem, 261, 4377, 10.1016/S0021-9258(17)38511-3 Lyons, 1990, Mechanism of activation of latent recombinant transforming growth factor β1 by plasmin, J Cell Biol, 110, 1361, 10.1083/jcb.110.4.1361